Literature DB >> 9250279

Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus.

M Syvänne1, M R Taskinen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9250279     DOI: 10.1016/s0140-6736(97)90024-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  34 in total

1.  Dyslipidaemia as a predictor of hypertension in middle-aged men.

Authors:  David E Laaksonen; Leo Niskanen; Kristiina Nyyssönen; Timo A Lakka; Jari A Laukkanen; Jukka T Salonen
Journal:  Eur Heart J       Date:  2008-02-28       Impact factor: 29.983

2.  Type 2 diabetes and cardiovascular diseases: do they share a common soil? The Asian Indian experience.

Authors:  Rajendra Pradeepa; Adamsha Nazir; Viswanathan Mohan
Journal:  Heart Asia       Date:  2012-01-01

Review 3.  Strategies for the management of diabetic dyslipidaemia.

Authors:  M R Taskinen
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 4.  Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis.

Authors:  Antonie J H H M van Oostrom; Jeroen van Wijk; Manuel Castro Cabezas
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 5.  Atherogenic dyslipidemia and combination pharmacotherapy in diabetes: recent clinical trials.

Authors:  Sandra J Hamilton; Gerald F Watts
Journal:  Rev Diabet Stud       Date:  2013-08-10

6.  "If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.

Authors:  Alexander Tenenbaum; Enrique Z Fisman
Journal:  Cardiovasc Diabetol       Date:  2010-06-15       Impact factor: 9.951

Review 7.  Diabetic dyslipidaemia: from basic research to clinical practice.

Authors:  M-R Taskinen
Journal:  Diabetologia       Date:  2003-05-28       Impact factor: 10.122

Review 8.  Anatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention.

Authors:  K P Morgan; A Kapur; K J Beatt
Journal:  Heart       Date:  2004-07       Impact factor: 5.994

Review 9.  Metabolic and additional vascular effects of thiazolidinediones.

Authors:  Fabrice M A C Martens; Frank L J Visseren; Jacinthe Lemay; Eelco J P de Koning; Ton J Rabelink
Journal:  Drugs       Date:  2002       Impact factor: 9.546

10.  Transient massive hyperlipidaemia in a type 2 diabetic subject.

Authors:  G B Vigna; A Passaro; K Bonomo; G Anfossi; R Fellin; M Trovati
Journal:  Intern Emerg Med       Date:  2007-03-31       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.